152 related articles for article (PubMed ID: 31591924)
1. Communication Experiences of DATA-Waivered Physicians with Community Pharmacists: A Qualitative Study.
Ventricelli DJ; Mathis SM; Foster KN; Pack RP; Tudiver F; Hagemeier NE
Subst Use Misuse; 2020; 55(3):349-357. PubMed ID: 31591924
[No Abstract] [Full Text] [Related]
2. Family physicians' perceptions of pharmacists prescribing in Alberta.
Faruquee CF; Khera AS; Guirguis LM
J Interprof Care; 2020; 34(1):87-96. PubMed ID: 31043099
[TBL] [Abstract][Full Text] [Related]
3. Community pharmacist-led clinical services: physician's understanding, perceptions and readiness to collaborate in a Midwestern state in the United States.
Gordon C; Unni E; Montuoro J; Ogborn DB
Int J Pharm Pract; 2018 Oct; 26(5):407-413. PubMed ID: 29218803
[TBL] [Abstract][Full Text] [Related]
4. Exploring successful community pharmacist-physician collaborative working relationships using mixed methods.
Snyder ME; Zillich AJ; Primack BA; Rice KR; Somma McGivney MA; Pringle JL; Smith RB
Res Social Adm Pharm; 2010 Dec; 6(4):307-23. PubMed ID: 21111388
[TBL] [Abstract][Full Text] [Related]
5. Buprenorphine physician-pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network.
Wu LT; John WS; Ghitza UE; Wahle A; Matthews AG; Lewis M; Hart B; Hubbard Z; Bowlby LA; Greenblatt LH; Mannelli P;
Addiction; 2021 Jul; 116(7):1805-1816. PubMed ID: 33428284
[TBL] [Abstract][Full Text] [Related]
6. A qualitative study on asthma management experiences of Turkish community pharmacists.
Ulutas Deniz E; Gülakar AN; Eren R
J Asthma; 2024 Jun; 61(6):632-642. PubMed ID: 38108630
[TBL] [Abstract][Full Text] [Related]
7. Perceptions of interprofessional collaboration of general practitioners and community pharmacists - a qualitative study.
Löffler C; Koudmani C; Böhmer F; Paschka SD; Höck J; Drewelow E; Stremme M; Stahlhacke B; Altiner A
BMC Health Serv Res; 2017 Mar; 17(1):224. PubMed ID: 28327136
[TBL] [Abstract][Full Text] [Related]
8. Pharmacist and physician perspectives on diabetes service delivery within community pharmacies in Indonesia: a qualitative study.
Wibowo Y; Sunderland B; Hughes J
Int J Pharm Pract; 2016 May; 24(3):180-8. PubMed ID: 26670327
[TBL] [Abstract][Full Text] [Related]
9. Interprofessional prescription opioid abuse communication among prescribers and pharmacists: A qualitative analysis.
Hagemeier NE; Tudiver F; Brewster S; Hagy EJ; Ratliff B; Hagaman A; Pack RP
Subst Abus; 2018 Jan; 39(1):89-94. PubMed ID: 28799863
[TBL] [Abstract][Full Text] [Related]
10. The physician perspective on pharmacist-physician collaboration and trust.
Amin S; McKeirnan KC
J Am Pharm Assoc (2003); 2022; 62(4):1304-1312. PubMed ID: 35346606
[TBL] [Abstract][Full Text] [Related]
11. Qualitative study to conceptualise a model of interprofessional collaboration between pharmacists and general practitioners to support patients' adherence to medication.
Rathbone AP; Mansoor SM; Krass I; Hamrosi K; Aslani P
BMJ Open; 2016 Mar; 6(3):e010488. PubMed ID: 26983948
[TBL] [Abstract][Full Text] [Related]
12. Physicians' perspectives of pharmacist-physician collaboration in the United Arab Emirates: Findings from an exploratory study.
Hasan S; Stewart K; Chapman CB; Kong DCM
J Interprof Care; 2018 Sep; 32(5):566-574. PubMed ID: 29589781
[TBL] [Abstract][Full Text] [Related]
13. A qualitative study exploring perceptions and attitudes of community pharmacists about extended pharmacy services in Lahore, Pakistan.
Hashmi FK; Hassali MA; Khalid A; Saleem F; Aljadhey H; Babar ZUD; Bashaar M
BMC Health Serv Res; 2017 Jul; 17(1):500. PubMed ID: 28724411
[TBL] [Abstract][Full Text] [Related]
14. Physician-pharmacist collaboration on chronic non-cancer pain management during the opioid crisis: A qualitative interview study.
Kang I; Urick B; Vohra R; Ives TJ
Res Social Adm Pharm; 2019 Aug; 15(8):1027-1031. PubMed ID: 31053466
[TBL] [Abstract][Full Text] [Related]
15. Collaborative prescribing: a qualitative exploration of a role for pharmacists in mental health.
Wheeler A; Crump K; Lee M; Li L; Patel A; Yang R; Zhao J; Jensen M
Res Social Adm Pharm; 2012; 8(3):179-92. PubMed ID: 21831724
[TBL] [Abstract][Full Text] [Related]
16. Using prescription dispensing data infographics to facilitate collaborative pharmacist-prescriber discussions on mutual patients.
Carroll JC; Renner HM; McGivney MS; Grapsy J; McCormick K; Cooney SS; Coley KC
J Am Pharm Assoc (2003); 2019; 59(2):232-237.e1. PubMed ID: 30638731
[TBL] [Abstract][Full Text] [Related]
17. Exploring the implementation of a medication adherence programme by community pharmacists: a qualitative study.
Marquis J; Schneider MP; Spencer B; Bugnon O; Du Pasquier S
Int J Clin Pharm; 2014 Oct; 36(5):1014-22. PubMed ID: 25139136
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular disease risk screening by pharmacists: a behavior change wheel guided qualitative analysis.
Almansour HA; Mekonnen AB; Aloudah NM; Alhawassi TM; Mc Namara K; Chaar B; Krass I; Saini B
Res Social Adm Pharm; 2020 Feb; 16(2):149-159. PubMed ID: 31027964
[TBL] [Abstract][Full Text] [Related]
19. Physicians' experiences with buprenorphine: A qualitative study of motivations for becoming X waivered and barriers to and facilitators of prescribing the medication for opioid use disorder.
McCollum CG; Eaton E; Creger T; Lee A; Gagnon K; Li L
Drug Alcohol Depend; 2023 Mar; 244():109777. PubMed ID: 36680808
[TBL] [Abstract][Full Text] [Related]
20. Informing collaborative relationships between community pharmacists and health care professionals in primary care practices.
Kauffman YS; Wright EA; Patterson BJ; Coley KC
J Am Pharm Assoc (2003); 2021; 61(6):778-784.e1. PubMed ID: 34303615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
